NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,353,077 | -15.3% | 30,578 | -6.9% | 0.01% | -12.5% |
| Q2 2023 | $1,597,654 | -12.4% | 32,833 | 0.0% | 0.02% | -11.1% |
| Q1 2023 | $1,822,888 | +38.2% | 32,833 | 0.0% | 0.02% | +50.0% |
| Q4 2022 | $1,318,902 | -1.5% | 32,833 | +7.4% | 0.01% | +20.0% |
| Q3 2022 | $1,339,000 | -34.0% | 30,561 | -46.6% | 0.01% | -33.3% |
| Q2 2022 | $2,029,000 | -41.1% | 57,262 | -32.3% | 0.02% | -25.0% |
| Q1 2022 | $3,443,000 | -52.5% | 84,641 | +9.0% | 0.02% | -55.6% |
| Q4 2021 | $7,250,000 | +91.9% | 77,628 | +129.0% | 0.04% | +36.4% |
| Q3 2021 | $3,778,000 | – | 33,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |